• $864.1M
    Market Cap
  • 179.61%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
09/30/2025
09/30/2024
09/30/2023
09/30/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
429,659
+932.83%
41,600
-65.16%
119,418
-78.36%
551,864
-35.24%
Research and Development Expense
-11.1M
+839.36%
-1.2M
-76.40%
-5.0M
-58.95%
-12.2M
+92.92%
Depreciation and Amortization Expense
76,868
+4.79%
73,357
+1.25%
72,450
+1,100.10%
6,037
N/A
Total Operating Expenses
784,078
+196.99%
264,009
-5.31%
278,809
-41.70%
478,248
+142.61%
Operating Profit
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Income before Taxes
-12.2M
+336.46%
-2.8M
-61.99%
-7.4M
-50.74%
-15.0M
+72.99%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-12.2M
+336.46%
-2.8M
-61.99%
-7.4M
-50.74%
-15.0M
+72.99%
Net Income from Continuing Operations Applicable to Common
-12.2M
+336.46%
-2.8M
-61.99%
-7.4M
-50.74%
-15.0M
+72.99%
Basic EPS and Net Income
-1.78
+173.85%
-0.65
-67.17%
-1.98
N/A
N/A
N/A
Diluted EPS and Net Income
-1.78
+173.85%
-0.65
-67.17%
-1.98
+63.64%
-1.21
N/A
Basic Weighted Average Shares
6.9M
+59.58%
4.3M
+15.87%
3.7M
-69.89%
12.4M
+37.64%
Diluted Weighted Average Shares
6.9M
+59.58%
4.3M
+15.87%
3.7M
-69.89%
12.4M
+37.64%
Balance Sheet
Cash and Cash Equivalents
82.9M
+1,349.43%
5.7M
-15.23%
6.7M
-41.97%
11.6M
-41.15%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
82.9M
+1,349.43%
5.7M
-15.23%
6.7M
-41.97%
11.6M
-41.15%
Total Current Assets
84.3M
+1,308.22%
6.0M
-12.12%
6.8M
-42.98%
11.9M
-40.37%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
84.4M
+1,282.92%
6.1M
-11.26%
6.9M
-43.09%
12.1M
-39.69%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
781,161
+47.76%
528,683
+88.24%
280,856
-80.93%
1.5M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
2.4M
+318.23%
568,259
+102.33%
280,856
-81.82%
1.5M
+141.86%
Retained Earnings
-46.6M
+35.60%
-34.3M
+8.88%
-31.5M
+30.50%
-24.2M
+162.49%
Total Stockholders Equity
82.0M
+1,381.93%
5.5M
-16.09%
6.6M
-37.41%
10.5M
-45.66%
Total Shares Outstanding
7.6M
+68.78%
4.5M
+19.94%
3.8M
-78.56%
17.6M
+48.65%
Cash Flow
Cash from Operating Activities
-8.7M
+369.77%
-1.9M
-73.66%
-7.0M
-48.30%
-13.6M
+85.63%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
85.6M
+10,456.43%
810,572
-62.98%
2.2M
-57.86%
5.2M
-80.06%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-27.02%
-37.40%
-43.16%
-44.48%
-77.74%
-16.55%
-93.16%
N/A
Return on Equity
-27.93%
-39.53%
-46.18%
-46.31%
-86.02%
-13.94%
-99.95%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
107.93
+853.07%
11.32
-53.31%
24.26
+198.94%
8.11
N/A
Cash Ratio
106.14
+880.96%
10.82
-54.97%
24.03
+204.26%
7.90
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow